Definition
Congenital (Primary) Immunodeficiencies are genetically determined defects that impair the development or function of the immune system. They may affect B cells, T cells, phagocytes, complement proteins, or combined pathways, leading to recurrent, severe, or unusual infections, autoimmune phenomena, and sometimes malignancies.
General Characteristics
- Usually manifest in infancy or early childhood.
- Patients often present with:
- Recurrent bacterial, viral, or fungal infections.
- Poor response to vaccination.
- Failure to thrive or growth retardation.
- Most are monogenic disorders, inherited in autosomal recessive or X-linked patterns.
- Can be classified based on the affected immune component (humoral, cellular, combined, etc.).
I. Severe Combined Immunodeficiency (SCID)
SCID represents a group of severe congenital disorders where both T-cell and B-cell immunity are profoundly impaired. Infants with SCID are extremely vulnerable to infections and typically die early without hematopoietic stem cell transplantation.
Genetic Types and Inheritance
- X-linked SCID (most common): mutation in IL2RG gene (γ-chain of IL-2 receptor).
- Autosomal recessive forms:
- Adenosine deaminase (ADA) deficiency
- JAK3 deficiency, RAG1/2 mutations, etc.
Adenosine Deaminase (ADA) Deficiency
Pathophysiology:
- 1. ADA enzyme is essential in purine metabolism → converts toxic deoxyadenosine to inosine.
- 2. ADA deficiency → accumulation of deoxyadenosine and dATP, which are toxic to lymphocytes.
- 3. The buildup inhibits DNA synthesis and lymphocyte proliferation.
- 4. Leads to severe lymphopenia → both T and B cell function severely compromised.
- 5. NK cells are also reduced → combined cellular and humoral immunodeficiency.
Clinical Features
- Onset in early infancy.
- Failure to thrive, chronic diarrhea, recurrent severe infections (bacterial, viral, fungal).
- Oral candidiasis, pneumonia, skin rashes.
- Absent thymic shadow on chest X-ray (due to thymic hypoplasia).
Diagnosis
- Lymphopenia (very low T, B, and NK cells).
- Low serum immunoglobulins.
- Enzyme assay → absent ADA activity.
- Confirmed by ADA gene mutation analysis.
Treatment
- Hematopoietic stem cell transplantation (HSCT): curative in most cases.
- Enzyme replacement therapy (PEG-ADA): improves survival until transplant.
- Gene therapy: ADA cDNA introduced into patient’s stem cells – long-term functional correction.